Legal status · Canada
Is Buntanetap legal in Canada?
No. Buntanetap is not approved for any medical use in Canada; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Preliminary.
Buntanetap in Canada at a glance
| Classification | Investigational, not approved |
|---|---|
| Health Canada approval status | Not approved by Health Canada; investigational |
| Evidence level | Preliminary (research strength: Moderate) |
| Reviewed | Sep 2026 |
Classification and note come from the Buntanetap profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
Buntanetap is being studied in registered clinical trials but has not received Health Canada marketing approval in Canada.
- 02
Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.
What Buntanetap is
An oral drug that lowers production of amyloid, tau and alpha-synuclein at once, now in an 850-patient Alzheimer's Phase 3 with a symptomatic readout due early 2027.
Buntanetap (Annovis Bio) inhibits translation of three neurotoxic proteins rather than clearing one of them after the fact. A Phase 2/3 was published in 2026, and the pTau217-confirmed Phase 3 fully enrolled in July 2026.
Mechanism: Inhibits the iron-responsive-element-regulated translation of APP, tau and alpha-synuclein mRNAs, reducing levels of all three proteins.
Regulatory history: Investigational; Phase 3
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Buntanetap at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Buntanetap in other countries
Frequently asked questions
Is Buntanetap legal in Canada?
No. Buntanetap is not approved for any medical use in Canada; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Preliminary.
Can I buy Buntanetap in Canada?
No approved product exists to buy. In Canada Buntanetap is classified as "Investigational, not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Buntanetap Health Canada approved?
No. In Canada Buntanetap is classified as "Investigational, not approved", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Investigational; Phase 3. Evidence level: Preliminary.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Buntanetap live on its compound profile.
Buntanetap profileThis page is general information about the regulatory status of Buntanetap in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.